ISLAMABAD -In a breakthrough development, the Vaccine for the deadlyCoronavirus developed by the scientists.
Following the outbreak of Coronavirus in December last year, Coalition forEpidemic Preparedness Innovations (CEPI) had allocated $12.5 million tothree medical firms to expedite the development of the vaccine of COVID-19;Moderna, Inovio, and University of Queensland.
Now, the researchers at Moderna are claiming that they have developed theCOVID-19 vaccine at unprecedented speed and will soon begin clinical trials.——————————
Moderna is a US-based biotechnology company that specializes in vaccinedevelopment by converting viral sequences into messenger RNA (mRNA).
Chief Medical Officer (CMO) at Moderna, Tal Zaks, says that the medicalfirm had already recruited volunteers for the clinical trials in the firstweek of March.
I don’t think proving the vaccine in an animal model is on the criticalpath to getting this to a clinical trial.
However, this is not the way how vaccine testing happens normally.
Medical firms around the globe are required to demonstrate beforeregulators that a newly developed vaccine has been tested and showedpositive results in lab animals before testing it on human beings.
Apparently, researchers at Moderna seem to be rushing towards releasing theCOVID-19 vaccine given the havoc the disease has wreaked across the globeso far.
Moderna’s decision to jump directly onto clinical trials has drawn mixedreactions from healthcare experts around the world.
Some suggest that the gravity of the Coronavirus pandemic is enough tojustify the decision. While some hold the view that Moderna’s act ismorally questionable as there will be unknown hazards for the humanvolunteers.
Akiko Iwasaki, a microbiologist at Yale University, termed Moderna’sdecision as unusual.
It reflects the urgency to develop vaccines to counter the COVID-19pandemic.
According to latest updates, Coronavirus has swept across 159 countries,killing 6,684 and infecting 174,090 people.






